APA

Gurm H. S., Sarembock I. J., Kereiakes D. J., Young J. J., Harrington R. A., Kleiman N., Feit F., Wolski K., Bittl J. A., Wilcox R., Topol E. J. & Lincoff A. M. (20050714). Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. : Journal of the American College of Cardiology.

Chicago

Gurm Hitinder S, Sarembock Ian J, Kereiakes Dean J, Young John J, Harrington Robert A, Kleiman Neal, Feit Frederick, Wolski Kathy, Bittl John A, Wilcox Robert, Topol Eric J and Lincoff A Michael. 20050714. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. : Journal of the American College of Cardiology.

Harvard

Gurm H. S., Sarembock I. J., Kereiakes D. J., Young J. J., Harrington R. A., Kleiman N., Feit F., Wolski K., Bittl J. A., Wilcox R., Topol E. J. and Lincoff A. M. (20050714). Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. : Journal of the American College of Cardiology.

MLA

Gurm Hitinder S, Sarembock Ian J, Kereiakes Dean J, Young John J, Harrington Robert A, Kleiman Neal, Feit Frederick, Wolski Kathy, Bittl John A, Wilcox Robert, Topol Eric J and Lincoff A Michael. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. : Journal of the American College of Cardiology. 20050714.